Lv3
398 积分 2024-02-20 加入
Safety considerations for cereblon-recruiting targeted protein degraders
10天前
已完结
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
10天前
已完结
Cancer Biology of GSPT1: Mechanisms and Targeted Therapy Opportunities of Molecular Glue Degraders
20天前
已完结
Discovery and Characterisation of Highly Cooperative FAK-Degrading PROTACs
1个月前
已完结
A Self-Assembled Irinotecan Nanomedicine Abrogates Steatohepatitis-Induced Liver Metastasis and Potentiates Antitumor Efficacy against Colorectal Cancer
2个月前
已完结
GSPT1 degraders: research progress, development strategies and challenges
4个月前
已完结
Molecular glues targeting GSPT1 in cancers: A potent therapy
4个月前
已完结
CD33‐Targeted Therapies: Beating the Disease or Beaten to Death?
4个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
5个月前
已完结
A competitive ligand binding assay for detection of neutralizing antibodies against an insulin analog
6个月前
已完结
皖公网安备34019202002308
